Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
18.62
+0.45 (2.48%)
At close: Aug 1, 2025, 4:00 PM
18.63
+0.01 (0.05%)
After-hours: Aug 1, 2025, 4:20 PM EDT
Chimerix Stock Forecast
Stock Price Forecast
The 3 analysts that cover Chimerix stock have a consensus rating of "Strong Buy" and an average price target of $40.33, which forecasts a 116.60% increase in the stock price over the next year. The lowest target is $26 and the highest is $55.
Price Target: $40.33 (+116.60%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Chimerix stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 1 |
Buy | 1 | 1 | 1 | 1 | 1 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 3 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $40 | Strong Buy | Initiates | $40 | +114.82% | Jul 14, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $26 | Buy | Initiates | $26 | +39.63% | Jul 11, 2025 |
Scotiabank | Scotiabank | Buy Initiates $55 | Buy | Initiates | $55 | +195.38% | Mar 7, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Aug 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jul 30, 2024 |
Financial Forecast
Revenue This Year
374.21M
from 358.71M
Increased by 4.32%
Revenue Next Year
408.80M
from 374.21M
Increased by 9.24%
EPS This Year
0.68
from 0.36
Increased by 88.75%
EPS Next Year
2.73
from 0.68
Increased by 300.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 387.3M | 431.5M | 502.0M | ||
Avg | 374.2M | 408.8M | 456.8M | ||
Low | 357.6M | 382.8M | 409.3M |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 8.0% | 15.3% | 22.8% | ||
Avg | 4.3% | 9.2% | 11.7% | ||
Low | -0.3% | 2.3% | 0.1% |
EPS Forecast
EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 0.70 | 2.81 | 3.70 | ||
Avg | 0.68 | 2.73 | 3.59 | ||
Low | 0.66 | 2.63 | 3.45 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|
High | 94.3% | 311.8% | 35.2% | ||
Avg | 88.8% | 300.0% | 31.3% | ||
Low | 81.4% | 284.3% | 26.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.